학술논문
KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy (CCRT) Followed by Pembrolizumab With or Without Olaparib vs. CCRT Followed by Durvalumab in Unresectable, Locally Advanced, Stage III Non‒Small-Cell Lung Cancer
Document Type
Article
Author
Source
In: International journal of radiation oncology, biology, physics . (International journal of radiation oncology, biology, physics, 1 November 2021, 111(3):e440-e441)
Subject
Language
English
ISSN
1879355X